Erythropoietin: a novel therapy for hypoxic–ischaemic encephalopathy?

Publisher： John Wiley & Sons Inc

ISSN： 0012-1622

Source： DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol.57, Iss.S3, 2015-04, pp. : 34-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoglycaemia and hypoxic–ischaemic encephalopathy

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 29-33

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neonatal seizures in hypoxic–ischaemic encephalopathy – risks and benefits of anticonvulsant therapy

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 40-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does aetiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy influence the outcome of treatment?

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 2-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

The long‐term health, social, and financial burden of hypoxic–ischaemic encephalopathy

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 48-50

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early predictors of outcome in infants treated with hypothermia for hypoxic–ischaemic encephalopathy

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 8-16

John Wiley & Sons Inc

Access to resources Recommend Favorite